Neo-Dankong Pharmaceutical Co.,Ltd was established in 2001,subordinate to Dankong Industry & Trade Group Co.,Ltd. Located in the state-level pharmaceutical and chemical raw material base. Neo-Dankong Pharmaceutical Co.,Ltd is a company to be listed combining manufacture, trade and scientific research. It mainly engages in R&D, manufacturing and marketing of pharmaceutical products in the fields such as anti-infection, cardiovascular and nervous system, with Norfloxacin, Atorvastatin series, Sertraline Hydrochloride, 4AA, new Peinan agent, Sulbactam Acid and other AIPs, intermediates and agents as its leading products, in which the production and sales of Norfloxacin ranks the 1st in the world and Statins enjoy a good reputation in the market.


Dankong possesses a comparative full and intensive quality management system and a rich-experienced team focusing on the quality management, registration and certification. Dankong passed the authentication of GMP, ISO9001, ISO14001, FDA, COS, MHRA, etc with several products occupying in the international leading position.


Neo-Dankong Pharmaceutical Co.,Ltd is a provincial high-tech enterprise with a R&D team consisting of more than 80 personnel. Based on the influence of the donation to the top universities in China, Dankong builds several united laboratories with Tsinghua University, Zhejiang University, Shanghai Institute of Pharmaceutical Industry and some scientific research institutes. Meanwhile Dankong employs a group of experts and professors to guide the research and development . All these factors promote Dankong鈥?s strength in process improvement, quality improvement, impurity studies, process innovation non-infringing patents, help gain advantage in the pharmaceutical products market, which offer strong technical support for the sustainable development of the enterprise. We applied for 12 items patents merely in 2007 and several products got patent approval in more than 20 countries.


So far, Dankong has established extensively cooperative relationship with more than 10 international corporations. It is predicated that dozens of new products will be brought to the market within the following 3 years. Looking forward to the future, Dankong will persist in the enterprise idea of 鈥淨uality first, honesty for foundation, pursuit of excellence, realization of win-win鈥? Relying on the advantage over the independent innovation, Dankong will develop more reliable products to contribute to the human health career.